Diwakar Davar

This study is testing whether pills containing healthy donor gut bacteria can help control severe skin rashes and colon inflammation in cancer patients. These side effects are caused by powerful immunotherapy drugs and often don't respond well to standard steroid treatments. The …

This study is testing an experimental drug called tebentafusp in people with metastatic uveal melanoma, a rare but aggressive eye cancer that has spread to other parts of the body. The trial will enroll 44 previously untreated patients who have a specific genetic marker (HLA-A*02…

This study is testing if a healthy donor stool transplant (FMT) can help the body fight cancer when given alongside the immunotherapy drug pembrolizumab. It is for people with advanced non-small cell lung cancer where prior immunotherapy has stopped working. The goal is to see if…

This study asks cancer patients which way they prefer to receive their immunotherapy drugs: as a quick injection under the skin or through a longer IV infusion. Researchers will enroll 480 people with various advanced cancers to compare comfort, convenience, and quality of life b…